Facing capacity issues and growing costs? Revolutionise your approach
Chronic Kidney Disease (CKD) effects 10% of the global population and is growing (8% CAGR).
It is extremely under diagnosed, with most people unaware they have it. There are now proven drugs such as SGLT2s that have been proven to slow the progression of CKD making it even more important to diagnose individuals earlier.
Current management practices are extremely expensive, e.g. CKD accounts for 20% of the US medicare budget.
There is already a lack of capacity of clinicians with WHO is forecasting a 10million shortage in the healthcare workers by 2030.
A proven care model for the whole kidney disease journey that delivers results
More people diagnosed earlier
Point of care testing in the community reaching more people and diagnosing more people earlier
Instant results with rich data and insights
Up to tenfold increase in outpatient capacity
Supported patient self management
MyRenalCare virtual consultations <5mins versus traditional face to face appointments
Zero Do Not Attends (NDAs)
Stable patients can be managed remotely by senior specialist nurses with consultant oversight
Better health outcomes
More educated, engaged and empowered patients, better equipped to self manage their condition
Continuous monitoring and oversight
Data driven decision making
Significant annual cost savings
MyRenalCare virtual consultations cheaper than traditional face to face
Reduced admissions and ward attendance
Less need for physical space
Potentially delays expensive renal replacement therapy
Delivers towards net zero
Less travel by both patients and clinicians
Less paper
Less physical space
Potentially delays resource intensive renal replacement therapy
Reduces risk of infectious diseases
Fewer face to face consultations and hospital visits